Bactiguard Holding AB (publ) (FRA:5JE)
Germany flag Germany · Delayed Price · Currency is EUR
1.275
-0.030 (-2.30%)
At close: Dec 5, 2025

Bactiguard Holding AB Company Description

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas.

It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded.

The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures.

It operates in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally.

The company has licensed partnership with Becton, Dickinson & Company for urinary catheter bardex IC and lubrisil IC; Well Lead Medical for catheters and tubes; and Zimmer Biomet for orthopedic trauma implants.

The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Bactiguard Holding AB (publ)
Country Sweden
Founded 2005
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees 177
CEO Christine Lind

Contact Details

Address:
Vasagatan 11
Stockholm, 111 20
Sweden
Phone 46 84 40 58 80
Website bactiguard.com

Stock Details

Ticker Symbol 5JE
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency SEK
SIC Code 3842

Key Executives

Name Position
Christine Lind Chief Executive Officer
Patrick Bach Chief Financial Officer